Welcome to our dedicated page for Canopy Growth news (Ticker: CGC), a resource for investors and traders seeking the latest updates and insights on Canopy Growth stock.
Canopy Growth Corporation (CGC) generates a steady flow of news as a cannabis-focused manufacturer with operations spanning medical and adult-use markets, branded products, and vaporization devices. The Canopy Growth news page on Stock Titan aggregates these disclosures so readers can follow how the company’s strategy, financing, and operations evolve over time.
Company news frequently covers financial performance and capital structure. Canopy Growth issues quarterly results releases that discuss cannabis and Storz & Bickel net revenue, segment performance in Canada and international markets, gross margins, operating loss, adjusted EBITDA, and free cash flow, along with commentary on cost management and balance sheet strength. The company also announces financing transactions, such as term loan agreements, prepayments on senior secured debt, convertible debenture exchanges, and at-the-market equity programs.
Another major category of news involves corporate transactions and governance. Canopy Growth has reported entering into an arrangement agreement to acquire MTL Cannabis Corp., detailing consideration, required approvals, and expected strategic benefits. It also publishes results of its annual general and special meetings, including director elections, auditor appointments, share consolidation authority, and advisory votes on executive compensation, as well as updates on board and executive appointments.
Product and market updates are a recurring theme. The company announces launches such as Claybourne Gassers liquid diamonds All-in-One vapes and Claybourne Frosted Flyers infused pre-roll variety packs in Canada, along with expansions of the Spectrum Therapeutics medical portfolio in Australia through new softgel formats. It also highlights operational moves like dedicating the DOJA facility in Kelowna to medical cultivation for Spectrum Therapeutics patients.
Investors and observers who monitor CGC news can use this page to track developments in Canopy Growth’s Canadian adult-use and medical businesses, its international medical operations in Europe and Australia, its indirect exposure to the U.S. THC market through Canopy USA, and its ongoing efforts to manage debt, liquidity, and governance matters. Bookmark this feed to review new press releases, transaction updates, and regulatory communications as they are published.
Canopy Growth Corporation (NASDAQ: CGC) has announced it will release its fourth quarter and fiscal year 2025 financial results on May 30, 2025, before market open. Following the release, CEO Luc Mongeau and CFO Judy Hong will host an audio webcast at 10 AM ET. The webcast will be available for replay until August 28, 2025.
Canopy Growth (NASDAQ: CGC) has launched new cannabis products targeting Canada's highest-demand adult-use categories. The company is focusing on four key formats: vapes, high-THC flower, pre-rolls, and edibles. Key product launches include:
- Advanced all-in-one vapes with CCELL technology featuring built-in displays for Tweed and 7ACRES brands
- New high-THC flower strains (Sour Sucker Mints and Blood Orange Kush) testing above 28% THC with 3.25-4% total terpenes
- Expanded pre-roll offerings including new Claybourne Frosted Flyers flavors and 7ACRES live resin-infused products
- Deep Space's entry into the edibles category with 10mg THC gummies containing natural caffeine
Canopy Growth (TSX: WEED) (Nasdaq: CGC) has launched Spectrum Reserve, a new premium medical cannabis brand in Canada through its medical division Spectrum Therapeutics. The brand focuses on premium genetics selected for size, potency, and terpene levels.
The program will introduce new strains regularly based on patient feedback, with successful strains remaining in market while others are phased out. The initial release includes four flower strains:
- Power Plant x Super Silver Haze (Indica, 22-25% THC, 2.21% terpenes)
- Grape Star x Golden Lemons (Sativa, 22-25% THC, 1.77% terpenes)
- Malawi x Kosher Tangie (Hybrid, 27-30% THC, 2.59% terpenes)
- Raspberry Parfait (Sativa-Dominant Hybrid, 22-27% THC, 2.59% terpenes)
Canopy Growth (TSX: WEED, Nasdaq: CGC) has made an optional early prepayment of US$100 million on its senior secured term loan at a discounted price of US$97.5 million. This strategic move will result in annual interest expense savings of approximately US$13 million.
The prepayment, completed under the Term Loan Amendment agreement with senior lenders, extends the loan's maturity date to September 18, 2027. The company had the option to make this Second Prepayment by March 31, 2025.
According to CFO Judy Hong, this action strengthens Canopy's balance sheet by reducing overall debt position and lowering annual interest costs, with no material debt obligations until September 2027.
Wana Brands, North America's leading edibles provider and a subsidiary of Canopy USA , has launched hemp-derived Delta-9 THC gummies in Texas, marking its 22nd state expansion. The product line includes eight varieties of gummies, each containing 20 pieces with 100mg THC and 100mg CBD in different flavors and effects combinations.
The products will be available at select retail locations across major Texas metropolitan areas including Austin, Dallas, and Houston. The product lineup features various formulations under the Balance, Relax, Inspire, and Dream Berry collections, each designed for specific wellness needs.
All products undergo third-party testing for potency, purity, and contaminants. This expansion beyond the Wanderous marketplace represents a strategic move to increase market share through improved product accessibility at local retail locations.
Wana Brands, a subsidiary of Canopy USA , has announced nationwide availability of its THC-infused beverages at Total Wine & More stores. The strategic partnership aims to meet growing consumer demand for health-conscious, zero-proof alcohol alternatives.
The product line features three varieties in 12 oz cans:
- Wana Lemonade Balance Blend (5mg each of CBG, CBD, THCA)
- Wana Strawberry Lemonade Balance Blend (10mg each of CBG, CBD, THCA)
- Wana Raspberry Tea Relax Blend (5mg each of CBG, CBD, THCA)
The beverages are available in select states including AZ, TX, IN, FL, NC, SC, KE, NE, and NJ, both in stores and online through totalwine.com. The products feature artwork by illustrator Beto Val and are formulated using hemp-derived cannabinoids for consistent effects.
Canopy Growth (NASDAQ: CGC) has announced a new US$200 million at-the-market equity program that enables the company to issue and sell common shares in concurrent public offerings in the United States and Canada. The shares will be sold at prevailing market prices through Nasdaq and TSX.
The net proceeds will be used for:
- Corporate investments and potential acquisitions
- Working capital and general corporate purposes
- Debt repayment, including an optional US$100 million prepayment that would extend the company's term loan maturity to September 18, 2027
The ATM Program will be effective until the earlier of the complete sale of shares, regulatory cessation, or July 5, 2026. BMO Nesbitt Burns Inc. and BMO Capital Markets Corp. will serve as agents for the program.
Canopy Growth (TSX: WEED) (NASDAQ: CGC) has launched its Tweed brand in the German medical cannabis market, introducing four new strains through a partnership with Portuguese cultivator Gro-Vida. The new offerings include Jack Herer (sativa-dominant), Balanced Caramel and Wappa (indica-prominent), and Gelato 33 (balanced hybrid).
This expansion follows the December 2024 launch of Tweed's Glitter Bomb strain in Germany through an agreement with German-based Cansativa. The company aims to provide consistent, reliable flower supply to meet growing patient demand for higher-THC genetics, leveraging both EU-based cultivators and their EU-GMP facility in Canada.
Canopy Growth (TSX: WEED) (NASDAQ: CGC) has expanded its Deep Space Propulsion beverage lineup with two new cannabis-infused flavors: Rocket Root Beer and Charged Cream Soda. These additions join the existing Blue Sourberry and Altitude Lemon Lime offerings.
Each 355ml can contains 10mg of THC, 10mg of CBG, and less than 30mg of naturally occurring caffeine. The beverages are crafted with natural flavors, with Rocket Root Beer featuring a deep, rich taste and Charged Cream Soda offering a smooth vanilla cream experience.
The new products are now available at licensed cannabis retailers across select Canadian regions and through the Spectrum Therapeutics online store for medical consumers.